Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine
Identifieur interne :
003057 ( PascalFrancis/Corpus );
précédent :
003056;
suivant :
003058
Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine
Auteurs : M. Gassen ;
A. Gross ;
M. B. H. YoudimSource :
-
Movement disorders [ 0885-3185 ] ; 1998.
RBID : Pascal:98-0177442
Descripteurs français
- Pascal (Inist)
- Parkinson maladie,
Apomorphine,
Chimiothérapie,
Agoniste,
Récepteur dopaminergique,
Neuroprotecteur,
Antioxydant,
Stress oxydatif,
Culture cellulaire,
Phéochromocytome,
Activité biologique,
Homme.
English descriptors
- KwdEn :
- Agonist,
Antioxidant,
Biological activity,
Cell culture,
Chemotherapy,
Dopamine receptor,
Human,
Neuroprotective agent,
Oxidative stress,
Parkinson disease,
Pheochromocytoma.
Notice en format standard (ISO 2709)
Pour connaître la documentation sur le format Inist Standard.
pA |
A01 | 01 | 1 | | @0 0885-3185 |
---|
A03 | | 1 | | @0 Mov. disord. |
---|
A05 | | | | @2 13 |
---|
A06 | | | | @2 2 |
---|
A08 | 01 | 1 | ENG | @1 Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine |
---|
A11 | 01 | 1 | | @1 GASSEN (M.) |
---|
A11 | 02 | 1 | | @1 GROSS (A.) |
---|
A11 | 03 | 1 | | @1 YOUDIM (M. B. H.) |
---|
A14 | 01 | | | @1 Department of Pharmacology, Eve Topf and National Parkinson's Foundation Centers for Neurodegenerative Diseases, Bruce Rappaport Family Research Institute, Faculty of Medicine, Technion @2 Haifa @3 ISR @Z 1 aut. @Z 2 aut. @Z 3 aut. |
---|
A20 | | | | @1 242-248 |
---|
A21 | | | | @1 1998 |
---|
A23 | 01 | | | @0 ENG |
---|
A43 | 01 | | | @1 INIST @2 20953 @5 354000079238580070 |
---|
A44 | | | | @0 0000 @1 © 1998 INIST-CNRS. All rights reserved. |
---|
A45 | | | | @0 27 ref. |
---|
A47 | 01 | 1 | | @0 98-0177442 |
---|
A60 | | | | @1 P |
---|
A61 | | | | @0 A |
---|
A64 | | 1 | | @0 Movement disorders |
---|
A66 | 01 | | | @0 USA |
---|
C02 | 01 | X | | @0 002B02B10 |
---|
C02 | 02 | X | | @0 235 |
---|
C03 | 01 | X | FRE | @0 Parkinson maladie @5 01 |
---|
C03 | 01 | X | ENG | @0 Parkinson disease @5 01 |
---|
C03 | 01 | X | SPA | @0 Parkinson enfermedad @5 01 |
---|
C03 | 02 | X | FRE | @0 Apomorphine @2 NK @2 FR @5 04 |
---|
C03 | 03 | X | FRE | @0 Chimiothérapie @5 05 |
---|
C03 | 03 | X | ENG | @0 Chemotherapy @5 05 |
---|
C03 | 03 | X | SPA | @0 Quimioterapia @5 05 |
---|
C03 | 04 | X | FRE | @0 Agoniste @5 06 |
---|
C03 | 04 | X | ENG | @0 Agonist @5 06 |
---|
C03 | 04 | X | SPA | @0 Agonista @5 06 |
---|
C03 | 05 | X | FRE | @0 Récepteur dopaminergique @5 07 |
---|
C03 | 05 | X | ENG | @0 Dopamine receptor @5 07 |
---|
C03 | 05 | X | SPA | @0 Receptor dopaminérgico @5 07 |
---|
C03 | 06 | X | FRE | @0 Neuroprotecteur @5 08 |
---|
C03 | 06 | X | ENG | @0 Neuroprotective agent @5 08 |
---|
C03 | 06 | X | SPA | @0 Neuroprotector @5 08 |
---|
C03 | 07 | X | FRE | @0 Antioxydant @5 09 |
---|
C03 | 07 | X | ENG | @0 Antioxidant @5 09 |
---|
C03 | 07 | X | SPA | @0 Antioxidante @5 09 |
---|
C03 | 08 | X | FRE | @0 Stress oxydatif @5 10 |
---|
C03 | 08 | X | ENG | @0 Oxidative stress @5 10 |
---|
C03 | 08 | X | SPA | @0 Stress oxidativo @5 10 |
---|
C03 | 09 | X | FRE | @0 Culture cellulaire @5 13 |
---|
C03 | 09 | X | ENG | @0 Cell culture @5 13 |
---|
C03 | 09 | X | SPA | @0 Cultivo celular @5 13 |
---|
C03 | 10 | X | FRE | @0 Phéochromocytome @5 14 |
---|
C03 | 10 | X | ENG | @0 Pheochromocytoma @5 14 |
---|
C03 | 10 | X | SPA | @0 Feocromocitoma @5 14 |
---|
C03 | 11 | X | FRE | @0 Activité biologique @5 17 |
---|
C03 | 11 | X | ENG | @0 Biological activity @5 17 |
---|
C03 | 11 | X | SPA | @0 Actividad biológica @5 17 |
---|
C03 | 12 | X | FRE | @0 Homme @5 20 |
---|
C03 | 12 | X | ENG | @0 Human @5 20 |
---|
C03 | 12 | X | SPA | @0 Hombre @5 20 |
---|
C07 | 01 | X | FRE | @0 Système nerveux pathologie @5 37 |
---|
C07 | 01 | X | ENG | @0 Nervous system diseases @5 37 |
---|
C07 | 01 | X | SPA | @0 Sistema nervioso patología @5 37 |
---|
C07 | 02 | X | FRE | @0 Système nerveux central pathologie @5 38 |
---|
C07 | 02 | X | ENG | @0 Central nervous system disease @5 38 |
---|
C07 | 02 | X | SPA | @0 Sistema nervosio central patología @5 38 |
---|
C07 | 03 | X | FRE | @0 Encéphale pathologie @5 39 |
---|
C07 | 03 | X | ENG | @0 Cerebral disorder @5 39 |
---|
C07 | 03 | X | SPA | @0 Encéfalo patología @5 39 |
---|
C07 | 04 | X | FRE | @0 Extrapyramidal syndrome @5 40 |
---|
C07 | 04 | X | ENG | @0 Extrapyramidal syndrome @5 40 |
---|
C07 | 04 | X | SPA | @0 Extrapiramidal síndrome @5 40 |
---|
C07 | 05 | X | FRE | @0 Maladie dégénérative @5 41 |
---|
C07 | 05 | X | ENG | @0 Degenerative disease @5 41 |
---|
C07 | 05 | X | SPA | @0 Enfermedad degenerativa @5 41 |
---|
N21 | | | | @1 117 |
---|
|
Format Inist (serveur)
NO : | PASCAL 98-0177442 INIST |
ET : | Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine |
AU : | GASSEN (M.); GROSS (A.); YOUDIM (M. B. H.) |
AF : | Department of Pharmacology, Eve Topf and National Parkinson's Foundation Centers for Neurodegenerative Diseases, Bruce Rappaport Family Research Institute, Faculty of Medicine, Technion/Haifa/Israël (1 aut., 2 aut., 3 aut.) |
DT : | Publication en série; Niveau analytique |
SO : | Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 1998; Vol. 13; No. 2; Pp. 242-248; Bibl. 27 ref. |
LA : | Anglais |
CC : | 002B02B10; 235 |
FD : | Parkinson maladie; Apomorphine; Chimiothérapie; Agoniste; Récepteur dopaminergique; Neuroprotecteur; Antioxydant; Stress oxydatif; Culture cellulaire; Phéochromocytome; Activité biologique; Homme |
FG : | Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative |
ED : | Parkinson disease; Chemotherapy; Agonist; Dopamine receptor; Neuroprotective agent; Antioxidant; Oxidative stress; Cell culture; Pheochromocytoma; Biological activity; Human |
EG : | Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease |
SD : | Parkinson enfermedad; Quimioterapia; Agonista; Receptor dopaminérgico; Neuroprotector; Antioxidante; Stress oxidativo; Cultivo celular; Feocromocitoma; Actividad biológica; Hombre |
LO : | INIST-20953.354000079238580070 |
ID : | 98-0177442 |
Links to Exploration step
Pascal:98-0177442
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H<sub>2</sub>
O<sub>2</sub>
and 6-hydroxydopamine</title>
<author><name sortKey="Gassen, M" sort="Gassen, M" uniqKey="Gassen M" first="M." last="Gassen">M. Gassen</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Pharmacology, Eve Topf and National Parkinson's Foundation Centers for Neurodegenerative Diseases, Bruce Rappaport Family Research Institute, Faculty of Medicine, Technion</s1>
<s2>Haifa</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Gross, A" sort="Gross, A" uniqKey="Gross A" first="A." last="Gross">A. Gross</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Pharmacology, Eve Topf and National Parkinson's Foundation Centers for Neurodegenerative Diseases, Bruce Rappaport Family Research Institute, Faculty of Medicine, Technion</s1>
<s2>Haifa</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Youdim, M B H" sort="Youdim, M B H" uniqKey="Youdim M" first="M. B. H." last="Youdim">M. B. H. Youdim</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Pharmacology, Eve Topf and National Parkinson's Foundation Centers for Neurodegenerative Diseases, Bruce Rappaport Family Research Institute, Faculty of Medicine, Technion</s1>
<s2>Haifa</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">98-0177442</idno>
<date when="1998">1998</date>
<idno type="stanalyst">PASCAL 98-0177442 INIST</idno>
<idno type="RBID">Pascal:98-0177442</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003057</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H<sub>2</sub>
O<sub>2</sub>
and 6-hydroxydopamine</title>
<author><name sortKey="Gassen, M" sort="Gassen, M" uniqKey="Gassen M" first="M." last="Gassen">M. Gassen</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Pharmacology, Eve Topf and National Parkinson's Foundation Centers for Neurodegenerative Diseases, Bruce Rappaport Family Research Institute, Faculty of Medicine, Technion</s1>
<s2>Haifa</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Gross, A" sort="Gross, A" uniqKey="Gross A" first="A." last="Gross">A. Gross</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Pharmacology, Eve Topf and National Parkinson's Foundation Centers for Neurodegenerative Diseases, Bruce Rappaport Family Research Institute, Faculty of Medicine, Technion</s1>
<s2>Haifa</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Youdim, M B H" sort="Youdim, M B H" uniqKey="Youdim M" first="M. B. H." last="Youdim">M. B. H. Youdim</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Pharmacology, Eve Topf and National Parkinson's Foundation Centers for Neurodegenerative Diseases, Bruce Rappaport Family Research Institute, Faculty of Medicine, Technion</s1>
<s2>Haifa</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1998">1998</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Agonist</term>
<term>Antioxidant</term>
<term>Biological activity</term>
<term>Cell culture</term>
<term>Chemotherapy</term>
<term>Dopamine receptor</term>
<term>Human</term>
<term>Neuroprotective agent</term>
<term>Oxidative stress</term>
<term>Parkinson disease</term>
<term>Pheochromocytoma</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Apomorphine</term>
<term>Chimiothérapie</term>
<term>Agoniste</term>
<term>Récepteur dopaminergique</term>
<term>Neuroprotecteur</term>
<term>Antioxydant</term>
<term>Stress oxydatif</term>
<term>Culture cellulaire</term>
<term>Phéochromocytome</term>
<term>Activité biologique</term>
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA08 i1="01" i2="1" l="ENG"><s1>Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H<sub>2</sub>
O<sub>2</sub>
and 6-hydroxydopamine</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>GASSEN (M.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>GROSS (A.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>YOUDIM (M. B. H.)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Pharmacology, Eve Topf and National Parkinson's Foundation Centers for Neurodegenerative Diseases, Bruce Rappaport Family Research Institute, Faculty of Medicine, Technion</s1>
<s2>Haifa</s2>
<s3>ISR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA20><s1>242-248</s1>
</fA20>
<fA21><s1>1998</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000079238580070</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 1998 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>27 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>98-0177442</s0>
</fA47>
<fA64 i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B02B10</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>235</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Apomorphine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Chimiothérapie</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Chemotherapy</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Quimioterapia</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Agoniste</s0>
<s5>06</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Agonist</s0>
<s5>06</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Agonista</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Récepteur dopaminergique</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Dopamine receptor</s0>
<s5>07</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Receptor dopaminérgico</s0>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Neuroprotecteur</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Neuroprotective agent</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Neuroprotector</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Antioxydant</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Antioxidant</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Antioxidante</s0>
<s5>09</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Stress oxydatif</s0>
<s5>10</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Oxidative stress</s0>
<s5>10</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Stress oxidativo</s0>
<s5>10</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Culture cellulaire</s0>
<s5>13</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Cell culture</s0>
<s5>13</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Cultivo celular</s0>
<s5>13</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Phéochromocytome</s0>
<s5>14</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Pheochromocytoma</s0>
<s5>14</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Feocromocitoma</s0>
<s5>14</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Activité biologique</s0>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Biological activity</s0>
<s5>17</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Actividad biológica</s0>
<s5>17</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07>
<fN21><s1>117</s1>
</fN21>
</pA>
</standard>
<server><NO>PASCAL 98-0177442 INIST</NO>
<ET>Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H<sub>2</sub>
O<sub>2</sub>
and 6-hydroxydopamine</ET>
<AU>GASSEN (M.); GROSS (A.); YOUDIM (M. B. H.)</AU>
<AF>Department of Pharmacology, Eve Topf and National Parkinson's Foundation Centers for Neurodegenerative Diseases, Bruce Rappaport Family Research Institute, Faculty of Medicine, Technion/Haifa/Israël (1 aut., 2 aut., 3 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Movement disorders; ISSN 0885-3185; Etats-Unis; Da. 1998; Vol. 13; No. 2; Pp. 242-248; Bibl. 27 ref.</SO>
<LA>Anglais</LA>
<CC>002B02B10; 235</CC>
<FD>Parkinson maladie; Apomorphine; Chimiothérapie; Agoniste; Récepteur dopaminergique; Neuroprotecteur; Antioxydant; Stress oxydatif; Culture cellulaire; Phéochromocytome; Activité biologique; Homme</FD>
<FG>Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative</FG>
<ED>Parkinson disease; Chemotherapy; Agonist; Dopamine receptor; Neuroprotective agent; Antioxidant; Oxidative stress; Cell culture; Pheochromocytoma; Biological activity; Human</ED>
<EG>Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease</EG>
<SD>Parkinson enfermedad; Quimioterapia; Agonista; Receptor dopaminérgico; Neuroprotector; Antioxidante; Stress oxidativo; Cultivo celular; Feocromocitoma; Actividad biológica; Hombre</SD>
<LO>INIST-20953.354000079238580070</LO>
<ID>98-0177442</ID>
</server>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003057 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 003057 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PascalFrancis
|étape= Corpus
|type= RBID
|clé= Pascal:98-0177442
|texte= Apomorphine enantiomers protect cultured pheochromocytoma (PC12) cells from oxidative stress induced by H2O2 and 6-hydroxydopamine
}}
| This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 | ![](Common/icons/LogoDilib.gif) |